Last reviewed · How we verify

NCT05728866

Effectiveness of IVR Combined With Task-Specific Training on Hemiplegic Arm Function Following Stroke

Completed NA Last updated 19 March 2026
What this trial tests

NA trial testing VR immersive therapy in Stroke in 13 participants. Completed in 20 November 2025.

Timeline
12 March 2023
Primary endpoint
20 November 2025
20 November 2025

Quick facts

Lead sponsorVirginia Commonwealth University
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationna
Designsingle group
Maskingnone
Primary purposesupportive care
Enrollment13
Start date12 March 2023
Primary completion20 November 2025
Estimated completion20 November 2025
Sites1 location across United States

Drugs / interventions tested

Conditions studied

Sponsor

Virginia Commonwealth University

Who can join

18 and older, any sex, with Stroke. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The purpose of this research study is to understand the efficacy of using an immersive Virtual Reality (VR) environment, with task-specific training, to encourage arm movement following stroke.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Stroke

Currently open trials in the same condition.

Other Virginia Commonwealth University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05728866.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing